These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 29484542)
1. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol. Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334 [TBL] [Abstract][Full Text] [Related]
3. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980 [TBL] [Abstract][Full Text] [Related]
4. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia. Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia. Krull KR; Cheung YT; Liu W; Fellah S; Reddick WE; Brinkman TM; Kimberg C; Ogg R; Srivastava D; Pui CH; Robison LL; Hudson MM J Clin Oncol; 2016 Aug; 34(22):2644-53. PubMed ID: 27269941 [TBL] [Abstract][Full Text] [Related]
6. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia. Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971 [TBL] [Abstract][Full Text] [Related]
7. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors. Chiou SS; Lin PC; Liao YM; Yang P Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia. Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029 [TBL] [Abstract][Full Text] [Related]
9. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only. Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396 [TBL] [Abstract][Full Text] [Related]
10. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only. Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140 [TBL] [Abstract][Full Text] [Related]
11. Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy. Cheung YT; Chemaitilly W; Mulrooney DA; Brinkman TM; Liu W; Banerjee P; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR Psychoneuroendocrinology; 2017 Feb; 76():114-118. PubMed ID: 27907849 [TBL] [Abstract][Full Text] [Related]
12. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. Cheung YT; Edelmann MN; Mulrooney DA; Green DM; Chemaitilly W; John N; Robison LL; Hudson MM; Krull KR Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1259-67. PubMed ID: 27345588 [TBL] [Abstract][Full Text] [Related]
13. Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG). Hardy KK; Embry L; Kairalla JA; Sharkey C; Gioia AR; Griffin D; Berger C; Weisman HS; Noll RB; Winick NJ Pediatr Blood Cancer; 2024 Nov; 71(11):e31179. PubMed ID: 39175358 [TBL] [Abstract][Full Text] [Related]
14. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation. Brace KM; Lee WW; Cole PD; Sussman ES J Clin Exp Neuropsychol; 2019 Oct; 41(8):814-831. PubMed ID: 31156064 [No Abstract] [Full Text] [Related]
15. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures. Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. Sabin ND; Cheung YT; Reddick WE; Bhojwani D; Liu W; Glass JO; Brinkman TM; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR AJNR Am J Neuroradiol; 2018 Oct; 39(10):1919-1925. PubMed ID: 30213807 [TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038 [TBL] [Abstract][Full Text] [Related]
18. Behavioral symptoms and psychiatric disorders in child and adolescent long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Liu W; Cheung YT; Brinkman TM; Banerjee P; Srivastava D; Nolan VG; Zhang H; Gurney JG; Pui CH; Robison LL; Hudson MM; Krull KR Psychooncology; 2018 Jun; 27(6):1597-1607. PubMed ID: 29521470 [TBL] [Abstract][Full Text] [Related]
19. Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia. van der Plas E; Spencer Noakes TL; Butcher DT; Weksberg R; Galin-Corini L; Wanstall EA; Te P; Hopf L; Guger S; Hitzler J; Schachar RJ; Ito S; Nieman BJ Pediatr Res; 2021 Aug; 90(2):419-426. PubMed ID: 33203967 [TBL] [Abstract][Full Text] [Related]
20. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review. Cheung YT; Krull KR Neurosci Biobehav Rev; 2015 Jun; 53():108-20. PubMed ID: 25857254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]